http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003022244-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
filingDate 2002-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_114901f877e4d1def82e151f20cff276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3118bdd3b1a8fbaf3462c2617692be91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff456b7f4a546937e324d864f550a77e
publicationDate 2003-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2003022244-A1
titleOfInvention Single chain antibody against mutant P53
abstract More than 90% of mutations found in the p53 protein produce a conformational change in p53 which results in the exposure of an epitope, which is otherwise hidden in the hydrophobic core of the molecule. A single chain antibody (scFv) which specifically recognizes this common mutant epitope in mutant p53 but not in wild type p53 is disclosed. Also described are a DNA molecule encoding the scFv, pharmaceutical compositions comprising the antibody and methods of treatment using the pharmaceutical compositions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113528467-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8853382-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012019058-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014093417-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11117976-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016154246-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007056352-A2
priorityDate 2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002155114-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6630584-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4816567-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5258498-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5618920-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5756669-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5091513-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127944238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032

Total number of triples: 53.